ArticleEJNMMI physics2026
Intravascular position-sensitive positron-counting catheter for atherosclerotic plaques.
Article in EJNMMI physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeRupture prone high-risk atheromatous plaques are characterized by large necrotic core volumes covered by thin fibrous caps which are positively remodeled; these plaques are significantly inflamed by the cells of monocyte-macrophage origin. We propose that the development of a position-sensitive positron-counting catheter, adding directionality with lead shields (sCath), would help record quantitative location-specific uptake of specifically targeted radiotracers against inflammation.
methodsFor in-vitro study, the catheter was placed on 18F point sources to measure the radioactivity counts. For ex-vivo study, the 9 aortas dissected from the rabbit model of atherosclerosis were exposed, and catheters were pulled back every 1 cm and counts measured the for 1 min by non-shielded catheter (nsCath), sCath-R (right side) and sCath-L (left side).
resultsIn-vitro study showed linear correlation between counts and 18F point source dose until at least 100 kBq (r = 0.98, p < 0.0001). In ex-vivo study, total 100 sections were obtained from 9 aortas and counts-per-minute (cpm) from each catheter nsCath, sCath-R, -L and the average of sCath-R and -L demonstrated high correlation coefficients with quantitative %ID/g (r = 0.49, 0.38, and 0.48, 0.48, respectively. p < 0.0001). They showed excellent agreement with ipsilateral macrophage numbers (sCath-R: r = 0.80, sCath-L: r = 0.73, p < 0.0001). Although the average macrophage numbers correlated with sCath-average of both sides (r = 0.80, p < 0.0001) and non-shielded Cath (nsCath) (r = 0.48, p < 0.0001), the positron count rate of sCath showed stronger correlation with ipsilateral macrohpage number.
conclusionThe directional superiority of sCath should potentially be useful in ecentric plaques for inflammation localization, compared with circumferential inflammatory load by the use of nsCath.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.